This is a past event. Registration is closed. View other The Society of Gynecologic Oncology of Canada events.
Join us for our very first FREE webinar series on Medical Cannabis.
Clinical Evidence for Use
- Review the existing evidence regarding the use of cannabis for oncologic related purposes
- Recognize the usage of cannabis for non-oncologic medical purposes
- Discuss making a choice about whether an oncologic patient may benefit from medical cannabis
The Pharmacology of Cannabis
- Review the endocannabinoid system
- Differentiate different cannabinoids and where they arise
- Define differences between THC and CBD
- Review the pharmacokinetics of cannabinoids
Regulations, Prescribing and Dosing Administration
- Describe the current Canadian regulations regarding the use of medical cannabis
- Review the common routes of administration of medical cannabis
- Discuss the administration and dosing of cannabinoid including dose titration and monitoring
- Describe potential side effects, contraindications, and drug interactions of medical cannabis
Toxicity/Safety
- Review the most common toxicity and safety issues related to medical cannabis usage
- Recognize those patients who could be at risk of serious toxicity
You do not want to miss this!
Agenda
19
00
-
19
05
Introduction
Jacob McGee19
05
-
19
30
19
30
-
19
50
The Pharmacology of Cannabis
Rachelle Findley19
50
-
20
05
Q&A
Jacob McGee•Rachelle Findley•Elena IgweThursday, February 10, 2022
19
00
-
19
05
Introduction
Jacob McGee19
05
-
19
25
Regulations, Dosing, and Administration of Medical Cannabis
Kristin Black•Ji-Hyun Jang19
25
-
19
40
Medical Cannabis: Toxicity and Safety
Elena Igwe19
40
-
20
00
Q&A
Jacob McGee•Ji-Hyun Jang•Kristin Black•Elena IgweThursday, February 17, 2022
Thursday, February 24, 2022
Introduction
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Introduction
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Introduction
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Introduction
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Medical Cannabis: Clinical Evidence for Use
Speakers
Elena Igwe
Gynecologic OncologistDr Igwe is a gynaecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
Regulations, Dosing, and Administration of Medical Cannabis
Speakers
Kristin Black
University of AlbertaKristin Black is a first-year Gynecologic Oncology fellow at the University of Calgary, and is concurrently taking the Master of Public Health program at the University of Victoria with a focus in Indigenous Health Studies. She completed a bachelor of science in biochemistry and medical school at the University of Saskatchewan, followed by Obstetrics and Gynecology residency at the University of Alberta. Her research interests include Indigenous health, ERAS and perioperative outcomes, and medical cannabis use in gynecologic oncology patients.
Ji-Hyun Jang
Physician at Western UniversityDr. Ji-Hyun Jang is an Assistant Professor in the Division of Gynecologic Oncology at Western University. She completed her MD and MPH at the University of Toronto and her Obstetrics & Gynecology residency and Gynecologic Oncology fellowship at UBC.
A conversation about cannabis and cancer: current status in symptom control and cancer therapy
Speakers
Paul Daeninck
Medical Oncologist at University of Manitoba/CancerCare ManitobaDr. Paul Daeninck is a medical oncologist and palliative medicine consultant with CancerCare Manitoba and the Winnipeg Regional Palliative Care Program. He is Chair of the Symptom Management and Palliative Care Disease Site with CancerCare Manitoba, and an Assistant Professor and Leader for the Palliative Care Longitudinal Theme at the Max Rady Medical School of the University of Manitoba.
Dr. Daeninck works with several national organizations, including the Canadian Society of Palliative Care Physicians, the Canadian Partnership Against Cancer and the Canadian Consortium for the Investigation of Cannabinoids (CCIC).
Dr. Daeninck is the author of several research papers as well as textbook chapters and serves as a reviewer for palliative medicine journals. He has an ongoing research interest in cannabinoid use in patients with cancer.
Medical Cannabis: Toxicity and Safety
Speakers
Elena Igwe
Gynecologic OncologistDr Igwe is a gynaecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
The Pharmacology of Cannabis
Speakers
Rachelle Findley
OBGYN/gynecologic oncologist at Alberta Health ServicesRachelle Findley hails from rural Southern Alberta. She completed her Bachelor of Science in Pharmacy at the University of Alberta and worked as a community pharmacist throughout her Medical degree in Edmonton. Obstetrics and Gynecology residency took her across the country to Halifax at Dalhousie University.
Having recently completed Gynecologic Oncology fellowship through the University of Calgary in 2021, she has since worked with the Gynecologic Oncology team at the Allan Blair Cancer Centre in Regina and started a master's program with the Johnson Shoyama Graduate School of Public Policy.
Q&A
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Ji-Hyun Jang
Physician at Western UniversityDr. Ji-Hyun Jang is an Assistant Professor in the Division of Gynecologic Oncology at Western University. She completed her MD and MPH at the University of Toronto and her Obstetrics & Gynecology residency and Gynecologic Oncology fellowship at UBC.
Kristin Black
University of AlbertaKristin Black is a first-year Gynecologic Oncology fellow at the University of Calgary, and is concurrently taking the Master of Public Health program at the University of Victoria with a focus in Indigenous Health Studies. She completed a bachelor of science in biochemistry and medical school at the University of Saskatchewan, followed by Obstetrics and Gynecology residency at the University of Alberta. Her research interests include Indigenous health, ERAS and perioperative outcomes, and medical cannabis use in gynecologic oncology patients.
Elena Igwe
Gynecologic OncologistDr Igwe is a gynaecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
Q&A
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Rachelle Findley
OBGYN/gynecologic oncologist at Alberta Health ServicesRachelle Findley hails from rural Southern Alberta. She completed her Bachelor of Science in Pharmacy at the University of Alberta and worked as a community pharmacist throughout her Medical degree in Edmonton. Obstetrics and Gynecology residency took her across the country to Halifax at Dalhousie University.
Having recently completed Gynecologic Oncology fellowship through the University of Calgary in 2021, she has since worked with the Gynecologic Oncology team at the Allan Blair Cancer Centre in Regina and started a master's program with the Johnson Shoyama Graduate School of Public Policy.
Elena Igwe
Gynecologic OncologistDr Igwe is a gynaecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
Q&A
Speakers
Jacob McGee
Physician at Victoria Hospital and Children's HospitalJacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Paul Daeninck
Medical Oncologist at University of Manitoba/CancerCare ManitobaDr. Paul Daeninck is a medical oncologist and palliative medicine consultant with CancerCare Manitoba and the Winnipeg Regional Palliative Care Program. He is Chair of the Symptom Management and Palliative Care Disease Site with CancerCare Manitoba, and an Assistant Professor and Leader for the Palliative Care Longitudinal Theme at the Max Rady Medical School of the University of Manitoba.
Dr. Daeninck works with several national organizations, including the Canadian Society of Palliative Care Physicians, the Canadian Partnership Against Cancer and the Canadian Consortium for the Investigation of Cannabinoids (CCIC).
Dr. Daeninck is the author of several research papers as well as textbook chapters and serves as a reviewer for palliative medicine journals. He has an ongoing research interest in cannabinoid use in patients with cancer.
Presentations and Recordings
Need to receive your CME credits? Fill out the following surveys
- February 3, 2022: https://forms.office.com/r/zCd3Qkf6cL
- February 10, 2022: https://forms.office.com/r/pzHh3EkFJ2.
- February 17, 2022: https://forms.office.com/r/NVtthPmUu7
- Submit your questions for the February 24, 2022, session: https://forms.office.com/r/X2XLPXZgvu. Answers to your questions will be posted here.
Watching the videos after the live sessions? You can still claim the credits when done.
February 24, 2022
Cannabis in the New Era of Pain Management with Dr. Collin Clarke.
This is a pre-recorded interview; there are no associated slides available to viewers.
February 17, 2022
A Conversation about Cannabis and Cancer: Current Status in Symptom Control and Cancer Therapy with Dr. Paul Daeninck.
This is a pre-recorded interview; there are no associated slides available to viewers.
February 10, 2022
Regulations, Prescribing and Dosing Administration
- Describe the current Canadian regulations regarding the use of medical cannabis;
- Review the common routes of administration of medical cannabis;
- Discuss the administration and dosing of cannabinoid including dose titration and monitoring;
- Describe potential side effects, contraindications, and drug interactions of medical cannabis.
Toxicity and Safety
- Review the most common toxicity and safety issues related to medical cannabis usage;
- Recognize those patients who could be at risk of serious toxicity.
February 3, 2022
The Pharmacology of Cannabis
- Review the endocannabinoid system;
- Differentiate different cannabinoids and where they arise;
- Define differences between THC and CBD;
- Review the pharmacokinetics of cannabinoids.
Medical Cannabis - Evidence of Use
- Review the existing evidence regarding the use of cannabis for oncologic related purposes;
- Recognize the usage of cannabis for non-oncologic medical purposes;
- Discuss making a choice about whether an oncologic patient may benefit from medical cannabis.
Speakers
Kristin
Black
University of Alberta
Kristin Black is a first-year Gynecologic Oncology fellow at the University of Calgary, and is concurrently taking the Master of Public Health program at the University of Victoria with a focus in Indigenous Health Studies. She completed a bachelor of science in biochemistry and medical school at the University of Saskatchewan, followed by Obstetrics and Gynecology residency at the University of Alberta. Her research interests include Indigenous health, ERAS and perioperative outcomes, and medical cannabis use in gynecologic oncology patients.
Collin
Clarke
London Health Sciences Centre
https://www.schulich.uwo.ca/anesthesia/people/faculty/clarke_collin.htmlDr. Collin Clarke is an Associate Professor in the Department of Anesthesia and Perioperative Medicine at Western University.
Following the completion of his anesthesia residency at Western University, Dr. Clarke completed an Interventional Pain Management Fellowship at Duke University Medical Center in North Carolina. During his fellowship, he focused primarily on the management of Complex Regional Pain as well as fluoroscopically guided interventions for the management of spinal mediated pain syndromes.
Currently he operates a pain clinic out of St. Joseph's hospital that involves both pharmacotherapy as well as a variety of interventions for treatment and management of a variety of pain syndromes. Additionally, Dr. Clarke provides anesthesia services at the London Health Sciences Center.
His research interests focus on functional imaging for the interpretation of pain pathways.
Paul
Daeninck
Medical Oncologist at University of Manitoba/CancerCare Manitoba
Dr. Paul Daeninck is a medical oncologist and palliative medicine consultant with CancerCare Manitoba and the Winnipeg Regional Palliative Care Program. He is Chair of the Symptom Management and Palliative Care Disease Site with CancerCare Manitoba, and an Assistant Professor and Leader for the Palliative Care Longitudinal Theme at the Max Rady Medical School of the University of Manitoba.
Dr. Daeninck works with several national organizations, including the Canadian Society of Palliative Care Physicians, the Canadian Partnership Against Cancer and the Canadian Consortium for the Investigation of Cannabinoids (CCIC).
Dr. Daeninck is the author of several research papers as well as textbook chapters and serves as a reviewer for palliative medicine journals. He has an ongoing research interest in cannabinoid use in patients with cancer.
Rachelle
Findley
OBGYN/gynecologic oncologist at Alberta Health Services
Rachelle Findley hails from rural Southern Alberta. She completed her Bachelor of Science in Pharmacy at the University of Alberta and worked as a community pharmacist throughout her Medical degree in Edmonton. Obstetrics and Gynecology residency took her across the country to Halifax at Dalhousie University.
Having recently completed Gynecologic Oncology fellowship through the University of Calgary in 2021, she has since worked with the Gynecologic Oncology team at the Allan Blair Cancer Centre in Regina and started a master's program with the Johnson Shoyama Graduate School of Public Policy.
Elena Igwe
Gynecologic Oncologist
Dr Igwe is a gynaecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
Ji-Hyun Jang
Physician at Western University
Dr. Ji-Hyun Jang is an Assistant Professor in the Division of Gynecologic Oncology at Western University. She completed her MD and MPH at the University of Toronto and her Obstetrics & Gynecology residency and Gynecologic Oncology fellowship at UBC.
Jacob McGee
Physician at Victoria Hospital and Children's Hospital
Jacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Tickets
Program Planning Committee
The following are the series program planning committee members:
Jacob McGee
Jacob McGee is a gynecologic oncologist and an associate professor in the Schulich School of Medicine at Western University. He is the regional gynecologic oncology champion for southwestern Ontario, a Director for the Gynecologic Oncology Group of Ontario (GOGO), and the incoming Secretary-Treasurer for The Society of Gynecologic Oncology of Canada. His research interests include optimizing testing for hereditary cancer syndromes and outcomes research using ICES (institute for clinical evaluative sciences) datasets.
Prafull Ghatage
Dr. Prafull Ghatage is Professor of Obstetrics & Gynecology and Oncology at the Cumming School of Medicine, Calgary. He is the Tumour Group Lead for the Guidelines Committee for Alberta, and the Program Director for Residency Training in Gynecologic Oncology. He is the Chair of the Examination Committee in Gynecologic Oncology, and the Co-Chair of the Examination Committee for Obstetrics and Gynecology for the Kuwaiti Board. He is co-lead (with Dr McGee) for the COP in Medical Cannabis for the GOC.
Kristin Black
Kristin Black is a first-year Gynecologic Oncology fellow at the University of Calgary, and is concurrently taking the Master of Public Health program at the University of Victoria with a focus in Indigenous Health Studies. She completed a bachelor of science in biochemistry and medical school at the University of Saskatchewan, followed by Obstetrics and Gynecology residency at the University of Alberta. Her research interests include Indigenous health, ERAS and perioperative outcomes, and medical cannabis use in gynecologic oncology patients.
Elena Igwe
Dr Igwe is a gynecologist oncologist practicing at Lakeridge Hospital in Oshawa, Ontario. She has trained in both the USA and Canada. She has recently completed a Masters in Healthcare Quality and has many diverse interests in improving the patients experience.
Rachelle Findley
Rachelle Findley hails from rural Southern Alberta. She completed her Bachelor of Science in Pharmacy at the University of Alberta and worked as a community pharmacist throughout her Medical degree in Edmonton. Obstetrics and Gynecology residency took her across the country to Halifax at Dalhousie University.
Having recently completed Gynecologic Oncology fellowship through the University of Calgary in 2021, she has since worked with the Gynecologic Oncology team at the Allan Blair Cancer Centre in Regina and started a master's program with the Johnson Shoyama Graduate School of Public Policy.
Ji-Hyun Jang
Dr. Ji-Hyun Jang is an Assistant Professor in the Division of Gynecologic Oncology at Western University. She completed her MD and MPH at the University of Toronto and her Obstetrics & Gynecology residency and Gynecologic Oncology fellowship at UBC.
Sponsors and Partners
Sponsor
Spectrum Therapeutics
Spectrum Therapeutics is an international medical cannabis company that raises the standard of care for patients with unmet medical needs. We make it easy for patients and healthcare professionals to understand how to optimize the therapeutic benefits of medical cannabis.
https://www.spectrumtherapeutics.com/canada/en/patients